CD40-CD40 ligand

Journal of Leukocyte Biology

Volumn 67, Issue 1, 2000, Pages 2-17

  Van Kooten, Gees ^b   Banchereau, Jacques ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B cells; CD154; Cytokines; Dendritic cells; Inflammation; Lymphocyte activation; T cells

Indexed keywords

CD40 ANTIGEN; CYTOKINE; GLYCOPROTEIN GP 39; INTERLEUKIN 12; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; B LYMPHOCYTE ACTIVATION; CELL SPECIFICITY; DENDRITIC CELL; ENDOTHELIUM CELL; GENE ACTIVATION; GENE STRUCTURE; HISTOCOMPATIBILITY; HUMAN; IMMUNOREGULATION; INFLAMMATION; LIGAND BINDING; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0004535499     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.67.1.2     Document Type: Review

References (128)

1. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., Van Kooten, C., Liu, Y. J., Rousset, F., Saeland, S. (1994) The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
2. Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E., Noelle, J. (1996) Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14, 591-617.
3. Grewal, I. S., Flavell, R. A. (1998) CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16, 111-135.
4. Van Kooten, C., Banchereau, J. (1996) CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61, 1-77.
5. Noelle, R. J. (1996) CD40 and its ligand in host defense. Immunity 4, 415-419.
6. Armitage. R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., Clark, E. A., Smith, C. A., Grabstein, K. H., Cosman, D., Spriggs, M. K. (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80-82.
7. Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., Aruffo, A. (1992) The human T antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11, 4313-4321.
8. Spriggs. M. K., Armitage. R. J., Strockbine, L., Clifford, K. N., Macduff, B. M., Sato, T. A., Maliszewski, C. R., Fanslow, W. C. (1992) Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176, 1543-1550.
9. Villa, A., Notarangelo, L. D., Di Santo, J. P., Macchi, P. P., Strina, D., Frattini, A., Lucchini, F., Patrosso, C. M., Giliani, S., Mantuano, E., Agosti, S., Nocera, G., Krozcek, R. A., Fisher, A., Ugazio, A. G., de Saint-Basile. G., Vezzoni, P. ( 1994) Organization of the human CD40L gene: implications for molecular defects in Χ chromosome-linked hyperIgM syndrome and prenatal diagnosis. Proc. Natl. Acad. Sci. USA 91, 2110-2114.
10. Renshaw, B. R., Fanslow, W. R., Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L., Maliszewski, C. R. (1994) Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889-1900.
11. Xu, J., Foy, T. M., Laman, J. D., Elliott, E. A., Dunn, J. J., Waldschmidt, T. J., Eisernere, J., Noelle, R. J., Flavell, R. A. (1994) Mice deficient for the CD40 ligand. Immunity 1, 423-431.
12. Mach, F., Schonbeck, U., Sukhova, G. K., Bourcier, T., Bonnefoy, J. Y., Pober, J. S., Libby, P. (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94, 1931-1936.
13. Henn, V., Slupsky, J. R., Grafe, M., Anagnostopoulos, I., Forster, R., Muller-Berghaus, G., Kroczek, R. A. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591-594.
14. Karpusas, M., Hsu, Y. M., Wang, J. H., Thompson, J., Lederman, S., Chess, L., Thomas, D. (1995) 2A crystal structure of an extracellular fragment of human CD40 ligand. Structure 3, 1031-1039.
15. Hsu, Y. M., Lucci, J., Su, L., Ehrenfels, B., Garber. E., Thomas, D. (1997) Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes. J. Biol. Chem. 272, 911-915.
16. Graf, D., Muller, S., Korthauer. U., van Kooten, C., Weise, C., Kroczek, R. A. (1995) A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25, 1749-1754.
17. Mazzei, G. J., Edgerton, M. D., Losberger, C., Lecoanet-Henchoz, S., Graber, P., Durandy, A., Gauchat, J. F., Bernard, A., Allet, B., Bonnefoy, J. Y. (1995) Recombinant soluble trimeric CD40 ligand is biologically active. J. Biol. Chem. 270, 7025-7028.
18. + T cells with dendritic cells. Eur. J. Immunol. 26, 3137-3143.
19. Pinchuk, L. M., Klaus, S. J., Magaletti, D. M., Pinchuk, G. V., Norsen, J. P., Clark, E. A. (1996) Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J. Immunol. 157, 4363-1370.
20. Grammer, A. G., Bergman, M. C., Miura, Y., Fujita, K., Davis, L. S., Lipsky. P. E. (1995) The CD40 ligand expressed by human B cells costimulates B cells responses. J. Immunol. 154, 4996-5010.
21. Carbone, E., Ruggiero, G., Terrazzano, G., Palomba, C., Manzo, C., Fontana, S., Spits, H., Karre, K., Zappacosta, S. (1997) A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185, 2053-2060.
22. Lederman, S., Yellin, M. J., Inghirami, G., Lee, J. J., Knowles, D. M., Chess, L. (1992) Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 149, 3817-3826.
23. Casamayor-Pelleja, M., Kahn, M., MacLennan. I. C. M. (1995) A subset of CD4memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J. Exp. Med. 181, 1293-1301.
24. Van den Eertwegh, A. J., Noelle. R. J., Roy, M., Shepherd, D. M., Aruffo, A., Ledbetter, J. A., Boersma, W. J., Claassen, E. (1993) In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp. Med. 178, 1555-1565.
25. Johnson-Leger, C., Christensen, J., Klaus, G. G. (1998) CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells. Int. Immunol. 10, 1083-1091.
26. Fuleihan, R., Ramesh, N., Horner, A., Ahern, D., Belshaw, P. J., Alberg, D. G., Stamenkovic, I., Harmon, W., Geha, R. S. (1994) Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J. Clin. Invest. 93, 1315-1320.
27. Stamenkovic, I., Clark, E. A., Seed, B. (1989) A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8, 1403-1410.
28. Torres, R. M., Clark, E. A. (1992) Differential increase of an alternatively polyadenylated mRNA species of murine CD40 upon B lymphocyte activation. J. Immunol. 148, 620-626.
29. Grimaldi. J. C., Kozak, C. A., Chang, R., Clark, E. A., Howard, M., Cockayne, D. A. (1992) Genomic structure and chromosomal mapping of the murine CD40 gene. J. Immunol. 149, 3921-3926.
30. Naismith, J. H., Sprang, S. R. (1998) Modularity in the TNF-receptor family. Trends Biol. Sci. 23, 74-79.
31. Singh, J., Garher, E., Van Vlijmen, H., Karpusas, M., Hsu. V M., Zheng, Z., Naismith, J. H., Thomas, D. (1998) The role of polar interactions in the molecular recognition of CD40L with its receptor CD40. Protein Sci. 7. 1124-1135.
32. Bajorath, J., Marken, J. S., Chalupny, N. J., Spoon, T. L., Siadak, A. W., Gordon, M., Noelle, R. J., Hollenbaugh, D., Aruffo, A. (1995) Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis. Biochemistry 34, 9884-9892.
33. Bajorath, J. (1998) Detailed comparison of two molecular models of the human CD40 ligand with an X-ray structure and critical assessment of model-based mutagenesis and residue mapping studies. J. Biol. Chem. 273, 24603-24609.
34. Notarangelo, L. D., Peitch, M. C. (1996) CD40Lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol. Today 17, 511-516.
35. Goldstein, M. D., Cochrane. A., Watts, T. H. (1997) Cyclic-AMP modulates downstream events in CD40-mediated signal transduction, but inhibition of protein kinase A has no direct effect on CD40 signaling. J. Immunol. 159, ,5871-5880.
36. Berberich, I., Shu. G., Siebelt. F., Woodgett, J. R., Kyriakis. J. M., Clark. E. A. (1996) Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than nutogen-activated protein kinases. EMBO J. 15, 92-101.
37. Grammer, A. C., Swantek. J. L, McFarland. R. D., Miura, Y., Geppert. T. Lipsky, P. E. (1998) TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells. J. Immunol. 161, 1183-1193.
38. Purkerson, J. M., Parker, D. C. (1998) Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway. J. Immunul. 160, 2121-2129.
39. Craxton, A., Shu, G., Graves, J. D., Saklalvala, J., Krebs, E. G., Clark, E. A. (1998) p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 161, 3225-3236.
40. Cheng, G., Clean, A. M., Ye, Z. S., Hong, D. I., Lederman, S., Baltimore, D. (1995) Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1498.
41. Xu, Y., Cheng, G., Baltimore, D. (1996) Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5, 407-115.
42. Rothe, M., Sarma, V., Dixit, V. M., Goeddel. D. V. (1995) TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269, 1424-1427.
43. Rothe, M., Xiong, J., Shu, H. B., Williamson, K., Goddard. A., Goeddel, D. V. (1996) I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc. Natl. Acad. Sci. USA 93, 8241-8246.
44. Park, Y. C., Burkitt. V., Villa, A. R., Tong, L., Wu, H. (1999) Structural basis for self-association and receptor recognition of human TRAF2. Nature 398, 533-538.
45. McWhirter, S. M., Pullen, S. S., Holton, J. M., Crute, J. J., Kehry, M. R., Alber, T. (1999) Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc. Natl. Acad. Sci. USA 96, 8408-8413.
46. Ishida, T, Tojo, T., Aoki, T, Kobayashi, N., Ohishi, T., Watanabe. T., Yamamoto, T., Inoue, J. (1996) TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93, 9437-9442.
47. Ishida, T., Mizushima, S., Azuma, S., Kobayashi, N., Tojo, T, Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., Kieff, E., Yamamoto, T., Inoue, J. (1996) Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745-28748.
48. Nakano, H., Sakon, S., Koseki, H., Takemori, T, Tada, K., Matsumoto. M., Munechika, E., Sakai, T., Shirasawa, T., Akiba, H., Kobata, T., Santee. S. M., Ware, C. F., Rennert, P. D., Taniguchi, M., Yagita, H., Okumura, K. (1999) Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc. Natl. Acad. Sci. USA 96, 9803-9808.
49. Hu, H. M., O'Rourke, K., Boguski, M. S., Dixit, V. M. (1994) A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069-30072.
50. Pullen, S. S., Miller. H. G., Everdeen, D. S., Dang, T. T. A., Crute. J. J., Kehry, M. R. (1998) CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37, 11836-11845.
51. Kashiwada, M., Shirakata. Y., Inoue, J. I., Nakano. H., Okazaki. K., Okumura, K., Yamamoto, T., Nagaoka, H., Takemori, T. (1998) Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway. J. Exp. Med. 187, 237-244.
52. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware. C., Kieff, E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor family. Cell 80, 389-399.
53. Kilger, E., Kieser, A., Baumann, M., Hammerschmidt, W. (1908) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700-1709.
54. Hatzivassiliou, E., Miller, W. E., Raab-Traub, N., Kieff, E., Mosialos, G. (1998) A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase. J. lmmunnl. 160, 1116-1121.
55. Chaudhuri, A., Orme, S., Eilam, S., Cherayil, B. J. (1997) CD40-mediated signals inhibit the binding of TNF receptor-associated factor 2 to the CD40 cytoplasmic domain. J. Immunol. 159. 4244-1251.
56. Hanissian, S. H., Geha, R. S. (1997) Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6, 379-387.
57. Kuhne, M. R., Robhins, M., Hambor, J. E., Mackey, M. F., Kosaka, Y., Nishimura, T., Gigley, J. P., Noelle, R. J., Calderhead, D. M. (1997) Assembly and regulation of the CD40 receptor complex in human B cells. J. Exp. Med. 186, 337-342.
58. Hsing, Y., Hostager, B. S., Bishop, G. A. (1997) Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J. Immunol. 159, 4898-4906.
59. Schauer, S. L., Bellas, R. E., Sonenshein, G. E. (1998) Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis. J. Immunol. 160, 4398-4405.
60. Karras, J. G., Wang, Z., Huo, L., Frank, D. A., Rothstein, T. L. (1997) Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement. J. Immunol. 159, 4350-1355.
61. Hu, B. T., Lee, S. C., Marin, E., Ryan, D. H., Insel, R. A. (1997) Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro. J. Immunol. 159, 1068-1071.
62. Arpin, C., Dechanet, J., Van Kooten, C., Merville, P., Grouard, G., Briere, F., Banchereau, J., Liu, Y. J. (1995) Generation of memory B cells and plasma cells in vitro. Science 268, 720-722.
63. Randall, T. D., Heath, A. W., Santos-Argumedo, L., Howard, M. C., Weissman, I. L., Lund, F. E. (1998) Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers, Immunity 8, 733-742.
64. Liu, Y. J., Malisan, F., de Bouteiller, O. Guret, C., Lebecque, S., Banchereau, J., Mills, F. C., Max, E. E., Martinez-Valdez, H. (1996) Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 4, 241-250.
65. Khanna, R., Cooper, L., Kienzle, N., Moss, D. J., Burrows, S. R., Khanna, K. K. (1997) Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells. J. Immunol. 159, 5782-5785.
66. Ballantyne, J., Henry, D. L., Muller, J. R., Briere, F., Snapper, C. M., Kehry, M., Marcu, K. B. (1998) Efficient recombination of a switch substrate retrovector in CD40-activated B lymphocytes: implications for the control of CH gene switch recombination. J. lmmunol. 161. 1336-1347.
67. Jeanin, P., Delneste, Y., Lecoanet-Henchoz, S., Gretener, D.,7 Bonnefoy, J. Y. (1998) Interleukin-7 (IL-7) enhances class switching to IgF, and IgG4 in the presence of T cells via IL-9 and sCD23. Blood 91, 1355-1361.
68. Jeannin, P., Lecoanet, S., Delneste, Y., Gauchat, J. E. Bonnefoy, J. Y. (1998) IgE versus IgG4 production can be differentially regulated by IL-10. J. Immunol. 160, 3555-3561.
69. Dubois, B., Vanbervliet, B., Fayette, J., Massacrier, C., Van Kooten, C., Briere, F, Banchereau, J., Caux, C. (1997) Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185, 941-951.
70. Fayette, J., Duhois, B., Vandenabeele, S., Bridon, J. M., Vanliervliet, B., Durand, J., Banchereau, J., Caux, C., Briere, F. (1997) Human dendritic cells skew isotype switching of CD40-artivated naive B cells towards IgA1 and IgA2. J. Exp. Med. 185, 1909-1918.
71. Cerutti, A., Schaffer, A., Shah, S., Zan, H., Liou, H. C., Goodwin, R. G., Casali, P. (1998) CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-anligen-selected human B cells. Immunity 9, 247-256.
72. Rothsiein, T. L., Wang, J. K. M., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S. T., Marshak-Rothstein, A. (1995) Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-165.
73. Galibert, L., Burdin, N., Barthelemy, C., Meffre, G., Durand, I., Garcia, E., Garrone, P., Roussel, F., Banchereau, J., Liu, Y. J. (1996) Negative selection of human germinal center B cells by prolonged BCR cross-linking. J. Exp. Med. 183, 2075-2085.
74. Rathmell, J. C., Townsend, S. E., Xu, J. C., Flavell, R. A., Goodnow, C. C. (1996) Expansion or elimination of B cells in vivo: dual roles for CD40 and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87, 319-329.
75. Stout, R. D., Suttles, J. (1996) The many roles of CD40 in cell-medialed inflammatory responses. Immunol. Today 17, 487-492.
76. Grewal, I. S., Flavell, R. A. (1996) A central role of CD40 ligand in the regulation of CD40 T cell responses. Immunol. Today 17, 410-414.
77. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
78. Mueller, C. G., Rissoan, M. C., Salinas, B., Ait-Yahia, S., Ravel, O., Bridon, J. M., Briere, F., Lebecque, S., Liu, Y. J. (1997) Polymerase chain reaction selects a novel disintegrin proteinase from GD40-activated germinal center dendritic cells. J. Exp. Med. 186, 655-663.
79. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic Cells. J. Exp. Med. 185, 341-349.
80. Van Essen, D., Kikutani, H., Gray, D. (1995) CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-623.
81. Poudrier, J., van Essen. D., Morales-Alcelay, S., Leanderson, T., Bergthorsdottir, S., Gray, D. (1998) CD40 ligand signals optimize T helper cell cytokine production: role in Th2 development and induction of germinal centers. Eur. J. Immunol. 28, 3371-3383.
82. Hayward, A. R., Levy. J., Facchetti Notarangelo, L., Ocihs, H. D., Etzioni, A., Bonnefoy, J. Y., Cosyns, M., Weinberg, A. (1997) Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 158, 977-983.
83. Hess, S., Engelmann, H. (1996) A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 183, 159-167.
84. Young, L. S., Eliopoulos, A. G., Gallagher, N. J., Dawson, C. W. (1998) CD40 and epithelial cells: across the great divide. Immunol. Today 19, 502-506.
85. Hirano, A., Longo, D. L., Taub, D. D., Ferris, D. K., Young, L. S., Eliopoulos, A. G., Agathanggelou, A., Cullen, N., Macartney, J., Fanslow, W. C., Murphy, W. J. (1999) Inhibition of human breast carcinoma growth by a soluble recumbinant human CD40 ligand. Blood 93, 2999-3007.
86. Garside, P., Ingulli, E., Merica, R. R., Johnson, J. G., Noelle R. J., Jenkins, M. K. (1998) Visualization of specific B and T lymphocyte intractions in the lymph node. Science 281, 96-99.
87. Kawahe, T., Naka, T. Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., Kikutani, H. (1994) The immune responses in CD40-defieient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178.
88. Durandy, A., Hivroz, C., Mazerolles, F., Schiff, C., Bernard, F., Jouanguy, E., Revy, P., DiSanto, J. P., Gauchat, J. F., Bonnefoy, J. Y., Casanova, J. L., Fischer, A. (1997) Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. J. Immunol. 158, 2576-258L.
89. Cantwell, M., Hua, T., Pappas, J., Kipps, T. J. (1997) Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nature Med. 3, 984-989.
90. Schattner, E. J., Mascarenhas, J., Reyfman, I., Koshy, M., Woo, C., Friedman, S. M., Crow, M. K. (1998) Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood 91, 2689-2697.
91. Dullforce, P., Sutton, D. C., Heath, A. W. (1998) Enhancement of T cell-independent immune responses in vivo by CD40 antibodies. Nature Med. 4, 88-91.
92. Gurunathan, S., Irvine, K. R., Wu, C. Y., Cohen, J. I., Thomas, E., Prussin, C., Restifo, N. P., Seder, R. A. (1998) CD40 ligand/trimer DNA enhances both humoral and rellular immune responses and induces protective immunity to infectious and tumor challenge. J. Imrnunol. 161, 4563-4571.
93. Campbell, K. A., Ovendale, P. J., Kennedy, M. K., Fanslow, W. C. Reed, S. G., Maliszewski, C. R. (1996) CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4, 283-280.
94. Kamanaka, M., Yu, P., Yasui, T., Yoshida, K., Kawabe, T., Horii, T., Kishimoto, T., Kikutani, H. (1996) Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4, 275-281.
95. Soong, L., Xu, J. C., Grewal, I. S., Kinta, P., Sun, J., Longley, B., Jr., Ruddle, N. H., McMahon-Pratt, D., Flavell, K. A. (1996) Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-273.
96. Stout, R. D., Suttles, J., Xu. J., Grewal, I. S., Flavell, R. A. (1996) Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. lmmunol. 156, 8-11.
97. Mackey, M. F., Barth, R. J., Jr., Noelle, R. J. (1998) The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukoc. Biol. 63, 418-428.
98. Buhlmann, J. E., Foy, T. M., Aruffo, A., Crassi, K. M., Ledbetter, J. A., Green, W. R., Xu, J. C., Shultz, L. D., Roopesian, D., Flavell, R. A., Fast, L., Noelle, R. J., Durie, F. H. (1995) In the absence of a CD40 signal, B cells are tolerogenie. Immunity 2, 645-653.
99. + T cell functions. J. Exp. Med. 183, 2209-2218.
100. + CTL response. J. Exp. Med. 183, 2129-2142.
101. Thomsen, A. R., Nansen, A., Christensen, J. P., Andreasen, S. O., Marker, O. (1998) CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J. lnimunol. 161, 4583-4590.
102. Bennetl, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F., Heath, W. R. (1998) Help for cytoloxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478-480.
103. + T-helper and a T-killer cell. Nature 393, 474-478.
104. Schoenberger, S. P., Toes. R. E., van der Voort, E. I., Offringa, R., Melief, C. J. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483.
105. French, R. R., Chan, H. T., Tutt, A. L., Glennie, M. J. (1999) CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nature Med. 5, 548-553.
106. Diehl, L., den Boer, A. T, Schoenberger, S. P., van der Voort, E. I., Schumacher, T. N., Melief, C. J., Offringa, R., Toes, R. E. (1999) CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumnr vaccine efficacy. Nature Med. 5, 774-779.
107. + T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nature Med. 5, 780-787.
108. Datta, S. K., Kalled, S. L. (1997) CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum. 40, 1735-1745.
109. Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., Datta, S. K. (1996) Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97, 2063-2073.
110. Koshy, M., Berger, D., Crow, M. K. (1996) Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98, 826-837.
111. Yellin, M. J., D'Agali, V., Parkinson, G., Han, A. S. Y., Szema, A., Baum, D., Estes, D., Szabolzs, M., Chess, L. (1997) lmmunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum. 40, 124-134.
112. Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A., Ledhetter, J. A., Boersrna, W. J. A., Claassen, E. (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93, 2499-2504.
113. Kalled, S. L., Cutler, A. H., Datta, S. K., Thomas, D. W. (1998) Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation ot kidney function. J. lmmunol. 160, 2158-2165.
114. Howard, L. M., Miga, A. J., Vanderlugt, C. L., Dal Canto, M. C., Laman, J. D., Noelle, R. J., Miller, S. D. (1999) Mechanisms of immunotherapeutic intervention by anti-C40I. (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103, 281-290.
115. Larsen, C. R. Pearson, T. C. (1997) The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr. Opin. Iminunol. 9, 641-647.
116. Elwood, E. T., Larsen, C. P., Cho, H. R., Corbascio, M., Ritchie, S. C., Alexander, D. Z., Tucker-Burden, C. Linsley, P. S., Aruffo, A., Hollenbaugh, D., Winn, K. J., Pearson, T. C. (1998) Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway hlockade. Transplantation 65, 1422-1428.
117. Larsen,C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., Winn, K. J., Pearson, T. C. (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438.
118. Sun, H., Subbotin, V., Chen, C., Aitouche, A., Valdivia, L. A., Sayegh, M. H., Linsley, P. S., Kung, J. J., Starzl, T. E., Rao, A. S. (1997) Prevention of chronic rejection in mouse aortic allografls by combined traetment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 64, 1838-1843.
119. Reul, R. M., Fang, J. C., Denton, M. D., Geehan, C., Long, C., Mitchell, R. N., Ganz, P., Briscoe, D. M. (1997) CD40 and CD40 ligand (CDL54) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 64, 1765-1774.
120. Zheng, X. X., Schachler, A. D., Vasconcellos, L., Strehlau, J., Tian, Y., Shapiro, M., Harmon, W., Strom, T. B. (1998) Increased CD40 ligand gene expression during human renal and murine islet allograft rejection. Transplantation 65, 1512-1515.
121. Kirk, A. D., Harlan, D. M., Armstrong, N. N., Davis, T. A., Dong, Y., Gray, G. S., Hong, X., Thomas, D., Fechner, J. H., Knechtle, S. J. (1997) CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in priniales. Proc. Natl. Acad. Sci. USA 94, 8789-8704.
122. Kirk, A. D., Burkly, L, C., Batty, D. S., Baumgartner, R. E., Berning, J. D., Buchanan, K., Fechner, J. H., Jr., Germond, R. L., Kampen, R. L., Patterson, N. B., Swanson, S. J., Tadaki, D. K., TenHoor, C. N., White, L., Knechtle, S. J., Harlan, D. M. (1999) Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med. 5, 686-693.
123. Laman, J. D., de Smet, B. J., Schoneveld, A., van Meurs, M. (1997) CD40-CD40I interactions in atherosclerosis. Immunol. Today 18, 272-277.
124. Mach, F.. Schonbeck, U., Sukhova, G. K., Atkinson, F., Libby, P. (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394, 200-203.
125. Schonbeck, U., Mach, F., Sukhova, G. K., Atkinson, E., Levesque, E., Herman, M., Graber, P., Basset, P., Libby, P. (1999) Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling In vitro and In vivo. J. Exp. Med. 189, 843-853.
126. Adawi, A., Zhang, Y., Baggs, R., Finkelstein, J., Phipps, R. P. (1998) Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrom. Am. J. Pathol. 152, 651-657.
127. Nonoyama, S., Shimadzu, M., Toru, H., Seyama, K., Nunoi, H., Neubauer, M., Yata, J., Och, H. D. (1997) Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum. Genet. 99, 624-627.
128. Gobburu, J. V., Tenhom, C., Rogge, M. C., Frazier, D. E., Jr., Thomas, D., Benjamin, C., Hess, D. M., Jusko, W. J. (1998) Pharmacokinetics/ dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys. J. Pharmacol. Exp. Ther. 286, 925-930.